Calls 15 and 16 of the Innovative Medicines Initiative.

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalised medicines for the health and wellbeing of all, especially in areas of unmet medical need.

Call 15 (386.722.862 EUR)

Topics

• IMI2-2018-15-01: Integrated research platforms enabling patient-centric drug development
• IMI2-2018-15-02: